APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Pharma and Life Science
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    Editor's Pick (1 - 4 of 8)
    left
    The 4Ps of Digital Transformation in Pharmaceutical Industry

    Debraj Dasgupta, Operating Officer, Head of Strategy and Go-To-Market Planning Division, Nippon Boehringer Ingelheim

    Cloud Computing: Pharma Takes the Plunge

    Andy Newsom, SVP & CIO, CSL Behring

    Machine Learning & Artificial Intelligence in Healthcare Industry

    James Woo, CIO, The Farrer Park Company

    Connected Patients: Healthcare and the Internet of Things

    Geoff Feakes, Group CIO, Tunstall Healthcare Group

    Building a Quality-Focused IT Foundation for a Biopharmaceutical Enterprise

    Andy Newsom, SVP, CIO, CSL Behring

    Points of Focus for CIOs to Succeed in the Next Decade and Beyond

    Dr. Joseph Frassica, CMIO/CTO, Patient Care and Monitoring Solutions, Philips Healthcare

    Innovating Technology -Based Metadata Solutions for Improved Data Analysis

    Douglas Barta, CIO, PAREXEL International

    Real-Time Actionable Intelligence with a Solid Analytics Platform

    Rajeev Nair,

    right

    Rapidly Evolving Technologies Improving Operational Efficiencies

    Dr.Subir Basak, President, Jubilant Drug Discovery & Development Services

    Tweet
    content-image

    Dr.Subir Basak, President, Jubilant Drug Discovery & Development Services

    The growing market of pharmaceuticals in India has propelled it to become one of the major industries in the country. The Indian pharmaceutical industry is highly fragmented with about 24,000 players (330 in the organized sector). Globally, the Indian pharmaceuticals market (IPM) is ranked 3rd largest in terms of volume and the 10th largest in terms of value. The industry has been posting a double digit growth on account of several socio-economic factors, including increasing sales of generic medicines, continued growth in chronic therapies, and a greater penetration in rural markets. India accounts for over 10 per cent of the global pharmaceutical production, with over 60,000 generic brands across 60 therapeutic categories; it manufactures more than 400 different active pharmaceutical ingredients (APIs). As per industry estimates, the pharmaceutical sales in India is expected to rise by 14.4 per cent to $27 billion in 2016 from last year.

    With rise in the number of outsourcing deals between domestic drug companies and pharmaceutical multinationals (MNCs), the demand for partnership between academia and industry for research drug development has come into mainstay. Today collaborations between industry and academia are promoted by open innovation programs, which have become a near-universal model for R&D.

    Hurdles encountered Pharmaceutical

    Companies, both domestic and international, face several major issues that include changing regulations, product life cycle management, patent protection, pre-clinical discovery and research and supply chain management. Also, the pharmaceutical output has remained stable over the past decade.

    Poor scientific productivity and the rise in expectations of customers have compounded to become one of the top priority hurdles of the industry.

    Jubilant offers customized innovative solutions across the drug discovery value chain, to the biotechnology and pharmaceutical industry. The discovery team focuses on early stage lead generation across various target classes. It also uses wide range of technologies, including High Throughput Screening, Molecular Modeling, and Medicinal Chemistry, Structural Biology and others, to identify novel starting points that are then selectively taken through the preclinical discovery process. The company provides flexibility through its business models so that it can cater to each client's requirements in the best possible manner.

    Penetration and Evolution of Technology

    In the past, the pharmaceutical sector has been sluggish in adopting new technologies when compared to other sectors like IT, software etc., but now the pharmaceutical sector is in tremendous pressure due to spiraling healthcare costs and demand for therapeutic needs of unmet clinical conditions. In order to adapt to these growing demand and address the issues that are emerging due to those, the sector is employing new technologies to complement its research efforts and also to reduce cost and time taken for the new drugs to hit the market.

    Technology innovation has become the core requirement for any organization that is looking for effective time and cost management. The company has worked on streamlining the supply process and has created processes that enables our scientists to procure their reagents electronically with minimal or no paperwork. From traditional way of writing data with pen and paper, the company has undertaken various technology measures to digitize data with robust security controls. Thus allowing the organization to systematically maintain records and archive. Since, it is these information and records that become of vital importance during the time of inquiry or regulation inspection.

    Also, the cloud computing technology has seen a rise in its popularity as it provides location and device independence. Thus allowing companies to share resources across large pools of users and enabling the scalability of services on a self-serve on real-time basis. The large amount of next generation sequencing data, the growing requirement for public– private partnerships (PPPs), and the need for integrating data sharing are just a few of the technology trends driving an increased interest in cloud computing by pharmaceutical and biotechnology companies. Data security is the major concern for pharmaceutical companies to take up cloud computing and the company hopes to present solutions that will address these issues effectively and make cloud computing more accessible for pharmaceutical companies.

    Rapidly evolving technologies are improving operational efficiencies and amplifying the performance of pharmaceutical and life sciences companies. These new and improved technologies jointly foster innovation through new ways of product development, data collection, regulatory reporting process, customer service and interaction, partnerships, thereby creating value and encouraging success.

    tag

    Pharmaceutical

    Cloud Computing

    Biotechnology

    Data Security

    Life Sciences

    Supply Chain Management

    Weekly Brief

    loading
    Top 10 Pharma and Life Science Technology Companies - 2020
    ON THE DECK

    Pharma and Life Science 2020

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Cultivating a Sustainable Future through Collaboration

    Cultivating a Sustainable Future through Collaboration

    Jiunn Shih, Chief Marketing, Innovation & Sustainability Officer, Zespri International
    Mastering Digital Marketing Strategies

    Mastering Digital Marketing Strategies

    Tasya Aulia, Director of Marketing and Communications, Meliá Hotels International
    Building a Strong Collaborative Framework for Artificial Intelligence

    Building a Strong Collaborative Framework for Artificial Intelligence

    Boon Siew Han, Regional Head of Humanoid Component Business & R&D (Apac & Greater China), Schaeffler
    From Legacy to Agility Through Digital Transformation

    From Legacy to Agility Through Digital Transformation

    Athikom Kanchanavibhu, EVP, Digital & Technology Transformation, Mitr Phol Group
    Change Management for Clinical Ancillary Teams: Aligning Practice with Policy and Progress

    Change Management for Clinical Ancillary Teams: Aligning Practice with Policy and Progress

    Ts. Dr. James Chong, Chief Executive Officer, Columbia Asia Hospital – Tebrau
    Digital Transformation: A Journey Beyond Technology

    Digital Transformation: A Journey Beyond Technology

    John Ang, Group CTO, EtonHouse International Education Group
    Building A Strong Data Foundation: The Key To Successful Ai Integration In Business

    Building A Strong Data Foundation: The Key To Successful Ai Integration In Business

    Richa Arora, Senior Director Of Data Governance, Cbre
    Transforming Tollways Through People, Data and Digital Vision

    Transforming Tollways Through People, Data and Digital Vision

    Carlo Cagalingan, Chief Digital Officer and Chief Information Officer, Metro Pacific Tollways Corporation
    Loading...
    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://pharma.apacciooutlook.com/cxoinsights/rapidly-evolving-technologies-improving-operational-efficiencies-nwid-538.html